Thermo Fisher Scientific Inc (NYSE:TMO) Insider Sells $366,645.22 in Stock

Thermo Fisher Scientific Inc (NYSE:TMO) insider Daniel P. Shine sold 2,026 shares of the stock in a transaction on Wednesday, August 30th. The stock was sold at an average price of $180.97, for a total value of $366,645.22. Following the completion of the sale, the insider now directly owns 20,682 shares in the company, valued at $3,742,821.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Shares of Thermo Fisher Scientific Inc (NYSE TMO) traded up 0.19% during midday trading on Friday, reaching $192.06. The company’s stock had a trading volume of 609,436 shares. The stock has a 50-day moving average of $179.77 and a 200 day moving average of $170.30. The company has a market cap of $74.93 billion, a price-to-earnings ratio of 33.46 and a beta of 1.05. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.92 billion. During the same quarter last year, the company posted $2.03 EPS. The company’s revenue was up 10.2% compared to the same quarter last year. On average, analysts predict that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 10.45%.

COPYRIGHT VIOLATION NOTICE: This piece was first posted by BBNS and is the sole property of of BBNS. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://baseballnewssource.com/markets/insider-selling-thermo-fisher-scientific-inc-tmo-insider-sells-2026-shares-of-stock/1565209.html.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BB&T Securities LLC lifted its stake in shares of Thermo Fisher Scientific by 4.4% during the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock valued at $13,798,000 after buying an additional 3,819 shares in the last quarter. Toronto Dominion Bank lifted its stake in shares of Thermo Fisher Scientific by 53.5% during the 1st quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock valued at $16,450,000 after buying an additional 37,307 shares in the last quarter. IBM Retirement Fund lifted its stake in shares of Thermo Fisher Scientific by 117.7% during the 2nd quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock valued at $1,860,000 after buying an additional 5,157 shares in the last quarter. Advisors Asset Management Inc. lifted its stake in shares of Thermo Fisher Scientific by 1.1% during the 1st quarter. Advisors Asset Management Inc. now owns 66,308 shares of the medical research company’s stock valued at $10,185,000 after buying an additional 735 shares in the last quarter. Finally, Cornerstone Investment Partners LLC lifted its stake in shares of Thermo Fisher Scientific by 41.7% during the 2nd quarter. Cornerstone Investment Partners LLC now owns 421,541 shares of the medical research company’s stock valued at $73,546,000 after buying an additional 123,954 shares in the last quarter. Institutional investors own 83.52% of the company’s stock.

Several equities research analysts have weighed in on TMO shares. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 target price on the stock in a research report on Tuesday, July 11th. Bank of America Corporation reissued a “buy” rating and set a $210.00 price target (up from $200.00) on shares of Thermo Fisher Scientific in a report on Friday, July 21st. Cleveland Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating in a report on Thursday, July 20th. Citigroup Inc. reissued a “buy” rating and set a $201.00 price target (up from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Finally, BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. One analyst has rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $193.56.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.